PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.\', \'Department of Rheumatology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.\', \'Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. li.xiaoyu@zs-hospital.sh.cn.\', \'Department of Pharmacy, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. lv.qianzhou@zs-hospital.sh.cn.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s00228-020-02962-5
?:hasPublicationType
?:journal
  • European journal of clinical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 32780229
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.159
?:rankingScore_hIndex
  • 96
?:title
  • Safety of hydroxychloroquine in COVID-19 and other diseases: a systematic review and meta-analysis of 53 randomized trials.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32780229>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32780229>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all